News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,109 Results
Type
Article (41232)
Company Profile (265)
Press Release (686596)
Multimedia
Podcasts (90)
Webinars (20)
Section
Business (204785)
Career Advice (2029)
Deals (35563)
Drug Delivery (128)
Drug Development (81482)
Employer Resources (173)
FDA (16483)
Job Trends (14973)
News (346703)
Policy (32752)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2592)
Accelerated approval (45)
Adcomms (25)
Allergies (165)
Alliances (49578)
ALS (198)
Alzheimer's disease (1758)
Antibody-drug conjugate (ADC) (420)
Approvals (16834)
Artificial intelligence (620)
Autoimmune disease (245)
Automation (52)
Bankruptcy (362)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (213)
Biotechnology (175)
Bladder cancer (182)
Brain cancer (68)
Breast cancer (708)
Cancer (5576)
Cardiovascular disease (454)
Career advice (1720)
Career pathing (41)
CAR-T (312)
CDC (54)
Celiac Disease (2)
Cell therapy (822)
Cervical cancer (44)
Clinical research (70480)
Collaboration (1982)
Company closure (4)
Compensation (1324)
Complete response letters (77)
COVID-19 (2732)
CRISPR (100)
C-suite (1047)
Cystic fibrosis (149)
Data (7420)
Decentralized trials (3)
Denatured (27)
Depression (156)
Dermatology (70)
Diabetes (560)
Diagnostics (6879)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (304)
Drug pricing (196)
Drug shortages (31)
Duchenne muscular dystrophy (270)
Earnings (91271)
Editorial (64)
Employer branding (21)
Employer resources (152)
Events (118862)
Executive appointments (1054)
FDA (20042)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1661)
Gene editing (215)
Generative AI (54)
Gene therapy (669)
GLP-1 (1030)
Government (4714)
Grass and pollen (6)
Guidances (402)
Healthcare (18964)
HIV (76)
Huntington's disease (52)
IgA nephropathy (93)
Immunology and inflammation (277)
Immuno-oncology (86)
Indications (167)
Infectious disease (3064)
Inflammatory bowel disease (204)
Inflation Reduction Act (14)
Influenza (134)
Intellectual property (278)
Interviews (317)
IPO (16656)
IRA (50)
Job creations (3646)
Job search strategy (1430)
JPM (58)
Kidney cancer (18)
Labor market (96)
Layoffs (557)
Leadership (37)
Legal (7951)
Liver cancer (98)
Longevity (31)
Lung cancer (746)
Lymphoma (416)
Machine learning (56)
Management (59)
Manufacturing (976)
MASH (179)
Medical device (13887)
Medtech (13973)
Mergers & acquisitions (20107)
Metabolic disorders (1439)
mRNA (188)
Multiple sclerosis (181)
NASH (17)
Neurodegenerative disease (388)
Neuropsychiatric disorders (101)
Neuroscience (3202)
Neurotech (1)
NextGen: Class of 2026 (6521)
Non-profit (4525)
Now hiring (75)
Obesity (675)
Opinion (283)
Ovarian cancer (205)
Pain (241)
Pancreatic cancer (279)
Parkinson's disease (348)
Partnered (33)
Patents (564)
Patient recruitment (626)
Peanut (61)
People (59398)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (21969)
Phase 2 (31042)
Phase 3 (23100)
Pipeline (7666)
Policy (307)
Postmarket research (2566)
Preclinical (9348)
Press Release (64)
Prostate cancer (283)
Psychedelics (52)
Radiopharmaceuticals (314)
Rare diseases (1015)
Real estate (5962)
Recruiting (70)
Regulatory (25166)
Reports (55)
Research institute (2410)
Resumes & cover letters (353)
Rett syndrome (34)
RNA editing (19)
RSV (88)
Schizophrenia (170)
Series A (273)
Series B (206)
Service/supplier (11)
Sickle cell disease (108)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (46)
Startups (3630)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (61)
Vaccines (1070)
Venture capital (101)
Weight loss (433)
Women's health (118)
Worklife (20)
Date
Last 7 days (752)
Last 30 days (2666)
Last 365 days (30205)
2026 (9844)
2025 (30171)
2024 (35213)
2023 (40075)
2022 (51174)
2021 (55709)
2020 (54082)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (739)
Alabama (91)
Alaska (7)
Arizona (339)
Arkansas (14)
Asia (39561)
Australia (6482)
California (12640)
Canada (3630)
China (1279)
Colorado (542)
Connecticut (546)
Delaware (381)
Europe (85491)
Florida (1894)
Georgia (407)
Hawaii (3)
Idaho (62)
Illinois (1004)
India (87)
Indiana (578)
Iowa (23)
Japan (510)
Kansas (129)
Kentucky (47)
Louisiana (39)
Maine (75)
Maryland (1522)
Massachusetts (9005)
Michigan (350)
Minnesota (690)
Mississippi (6)
Missouri (143)
Montana (33)
Nebraska (29)
Nevada (137)
New Hampshire (84)
New Jersey (3354)
New Mexico (28)
New York (3333)
North Carolina (1604)
North Dakota (8)
Northern California (6289)
Ohio (376)
Oklahoma (23)
Oregon (41)
Pennsylvania (2555)
Puerto Rico (28)
Rhode Island (50)
South America (1112)
South Carolina (85)
South Dakota (2)
Southern California (4975)
Tennessee (203)
Texas (1998)
United States (44717)
Utah (378)
Vermont (1)
Virginia (299)
Washington D.C. (80)
Washington State (1014)
West Virginia (4)
Wisconsin (121)
Wyoming (2)
728,109 Results for "protokinetix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Research Paper Incorporating ProtoKinetix AAGP® Submitted to Scientific Journal for Publication
ProtoKinetix, Incorporated, a clinical-stage biomedical company, announced the submission of a research paper describing cell characterization, graft evaluation, and yield of islet-like cells differentiated from patient-derived iPSCS for the treatment and eventual cure of Type-1 Diabetes for publication in Cell Stem Cell, a peer-reviewed scientific journal published by Cell Press.
June 6, 2023
·
3 min read
Press Releases
Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.
March 25, 2026
·
3 min read
Press Releases
NeurAxis, Inc. Announces Preferred Stock Dividend
April 10, 2026
·
3 min read
Press Releases
/U P D A T E -- Nuvation Bio Inc./
April 22, 2026
·
14 min read
Press Releases
Immunic, Inc. Announces 1-for-10 Reverse Stock Split
April 23, 2026
·
7 min read
Press Releases
Milestone Scientific Inc. Completes $2.15 Million Private Placement
April 21, 2026
·
4 min read
Press Releases
LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.
April 21, 2026
·
5 min read
Press Releases
Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report
April 24, 2026
·
1 min read
Press Releases
RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6
April 23, 2026
·
1 min read
Drug Development
ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants
ProtoKinetix, Incorporated ( www.protokinetix.com ) (the “Company” or “ProtoKinetix”) (OTCQB: PKTX ), a clinical-stage biomedical company, today announced that the University of Alberta has successfully completed Phase 1 clinical trial enrollment for the treatment of type 1 diabetes in islet cell transplants.
July 20, 2022
·
2 min read
1 of 72,811
Next
